194 related articles for article (PubMed ID: 9714110)
1. Abnormalities of the extracellular degradation of collagen type I in essential hypertension.
Laviades C; Varo N; Fernández J; Mayor G; Gil MJ; Monreal I; Díez J
Circulation; 1998 Aug; 98(6):535-40. PubMed ID: 9714110
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
Li-Saw-Hee FL; Edmunds E; Blann AD; Beevers DG; Lip GY
Int J Cardiol; 2000 Aug; 75(1):43-7. PubMed ID: 11054505
[TBL] [Abstract][Full Text] [Related]
3. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta in hypertensives with cardiorenal damage.
Laviades C; Varo N; Díez J
Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
[TBL] [Abstract][Full Text] [Related]
5. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
Lindsay MM; Maxwell P; Dunn FG
Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
[TBL] [Abstract][Full Text] [Related]
6. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats.
Varo N; Iraburu MJ; Varela M; López B; Etayo JC; Díez J
Hypertension; 2000 Jun; 35(6):1197-202. PubMed ID: 10856263
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of benidipine hydrochloride on severe left ventricular hypertrophy and collagen metabolism in patients with essential hypertension.
Hirono O; Fatema K; Nitobe J; Takeishi Y; Kaneko K; Shiga R; Kubota I
J Cardiol; 2002 Apr; 39(4):195-204. PubMed ID: 11977767
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment.
Onal IK; Altun B; Onal ED; Kirkpantur A; Gul Oz S; Turgan C
Eur J Intern Med; 2009 Jul; 20(4):369-72. PubMed ID: 19524176
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
10. Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
Niemirska A; Litwin M; Trojanek J; Gackowska L; Kubiszewska I; Wierzbicka A; Kułaga Z; Michałkiewicz J
J Hypertens; 2016 Sep; 34(9):1815-22. PubMed ID: 27379542
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophy.
A Romero C; Mathew S; Wasinski B; Reed B; Brody A; Dawood R; Twiner MJ; McNaughton CD; Fridman R; Flack JM; Carretero OA; Levy PD
J Clin Hypertens (Greenwich); 2021 May; 23(5):1008-1016. PubMed ID: 33694311
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Tayebjee MH; Nadar SK; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):770-4. PubMed ID: 15363818
[TBL] [Abstract][Full Text] [Related]
14. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ovchinnikov AG; Serbul VM; Ageev FT
Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
[TBL] [Abstract][Full Text] [Related]
15. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis.
Díez J; Panizo A; Gil MJ; Monreal I; Hernández M; Pardo Mindán J
Circulation; 1996 Mar; 93(5):1026-32. PubMed ID: 8598066
[TBL] [Abstract][Full Text] [Related]
16. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Li H; Simon H; Bocan TM; Peterson JT
Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
[TBL] [Abstract][Full Text] [Related]
18. Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy.
Timms PM; Wright A; Maxwell P; Campbell S; Dawnay AB; Srikanthan V
Am J Hypertens; 2002 Mar; 15(3):269-72. PubMed ID: 11939619
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
[TBL] [Abstract][Full Text] [Related]
20. Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy.
Ishikawa J; Kario K; Matsui Y; Shibasaki S; Morinari M; Kaneda R; Hoshide S; Eguchi K; Hojo Y; Shimada K
Hypertens Res; 2005 Dec; 28(12):995-1001. PubMed ID: 16671339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
